Navigation Links
QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System
Date:7/28/2009

g L-PPDS is roughly equivalent to 54 latanoprost eye drops, or about 60% of the amount of drug in eye drops given continuously over three months.

Concurrent with the Phase II clinical trial, punctal plug prototype designs for the sustained delivery system are being tested in an ongoing multicenter study in more than 500 healthy volunteers. Safety, tolerability, comfort, ease of handling and insertion/removal, and retention are being assessed in this study. The overall goal for development is to achieve 90% retention for 90 days. Based on currently available data, preliminary results for one family of designs show an overall retention rate of 75% after eight weeks of follow-up. While this does not yet meet the Company's retention criteria, designs are continuing to be refined and evaluated, with longer-term follow-up on the improved designs anticipated by year-end.

"We are pleased with the progress of our Phase II clinical trial and device program," said Bob Butchofsky, President and Chief Executive Officer of QLT. "The interim data we announced today are encouraging and are in line with the data we reported from our earlier CORE study. The results observed at Week 4 are clinically meaningful and similar to the IOP decrease we saw in the CORE study at the same time point. We believe there is sufficient room to increase the dose of latanoprost to further increase reduction in IOP while maintaining a favorable safety profile, and we look forward to updating you on the clinical progress of our higher dose evaluations. We continue to refine our designs for punctal plugs and anticipate that these will lead to improved retention rates in ongoing clinical trials."

The 44-(micro)g Phase II Study

This study includes two cohorts and is an ongoing, Phase II, open-label, multicenter study conducted to investigate the safety and preliminary efficacy of L-PPDS containing either 44-(micro)g (first cohort) or 81-(micro)g (second coho
'/>"/>

SOURCE QLT Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. QLT Announces Second Quarter Results for 2009
2. MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Advantage
3. Grupo Casa Saba Announces Quarterly Earnings Report 2Q09
4. Image Sensors 2009 Announces Final Program and New Interactive Brochure
5. ULURU Inc. Announces Status of York Note Receivable
6. Danaher Corporation Announces Retirement of Executive Vice President Philip W. Knisely
7. Paradigm Spine Closes $21.5 Million Financing and Announces Promotion of Matt Stuttle to Position of Vice President, US Sales
8. Electronic Healthcare Network Announces Multi-State Expansion, Beginning in Buffalo, NY
9. Association of Gaming Equipment Manufacturers (AGEM) Announces $100,000 in Contributions to Organizations Working to Assist Problem Gamblers
10. American DG Energy Announces $3.5 Million Private Placement
11. Brookdale Announces Second Quarter 2009 Release and Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Lighthouse Payment Services ... announced that it will exhibit its image-based lockbox services ... 41st annual convention in beautiful Lake Placid, New ... event will be held at the Lake Placid Convention ... and entertainment options in addition to a variety of ...
(Date:8/27/2014)... 2014 Aspirus Wausau Hospital today announced ... with Buzz™ Digital O.R. at Aspirus Wausau Hospital, in ... new operating rooms will be Buzz, a centralized surgical ... system supports planning, navigation, imaging and communications connectivity. ... intuitive software and hardware all controlled from the full ...
(Date:8/27/2014)... Health care workers in poor nations often do not ... being infected with blood-borne viruses such as Ebola and ... was conducted before the current Ebola outbreak began in ... statistics released Monday by the World Health Organization (WHO). ... number of health care workers have lost their lives ...
(Date:8/27/2014)... Stroke patients are 70 per cent more likely to ... if they have a prescription in hand when discharged ... and the Institute for Clinical Evaluative Sciences (ICES). , ... many Ontarians were taking their medications one week, one ... results reveal the importance of simple interventions, such as ...
(Date:8/27/2014)... Chino Hills, CA (PRWEB) August 27, 2014 ... boot camp franchise in the world, the leading fitness ... to Spike TV’s Gym Rescue reality series. One thing he ... personal brand as a subject matter expert in the fitness ... uploaded to YouTube, he lays out a step-by-step instructional guide ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 2Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 3Health News:A prescription for better stroke care 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3
... , ... Fresh Look at Coping with Multiple Sclerosis through Community , ... (PRWEB) April 13, 2010 -- Motivational Speaker/MS ... guidebook for those newly diagnosed with Multiple Sclerosis. , , ,Published by iUniverse ...
... likely to develop, die from disease , TUESDAY, April 13 ... comes to both developing and dying from lung cancer. , ... grim picture of how environmental factors, biological factors, cultural attitudes ... deadly disease even deadlier among members of this minority group. ...
... ... patients and may be covered by medical insurance will be provided by Khanna institute in ... (Vocus) April ... with countless solutions for eye and sight problems, hereby announces that it is offering its ...
... mutated gene in human cancers is the reitnoblastoma (RB) gene, ... gene disable the vast and intricate RB pathway in virtually ... cellular functions and ultimately provoking cancer. But which of these ... uncertain. "We have now found that a key function ...
... ... general availability of ActiveStrategy iRound™, which enables field-level performance management data to be ... Enterprise software. , ... (PRWEB) April 13, 2010 -- ActiveStrategy, the leading provider of comprehensive ...
... on failure rates could aid surgeons who import donor tissue, ... a corneal transplant will fail is not affected by the ... transplanted cornea was preserved or the method of preservation, according ... study that included 388 people who were followed for up ...
Cached Medicine News:Health News:Author Erin Morrow Still Releases "Fighting MS: Strength in Numbers" 2Health News:Author Erin Morrow Still Releases "Fighting MS: Strength in Numbers" 3Health News:Blacks Hit Hardest by Lung Cancer 2Health News:Blacks Hit Hardest by Lung Cancer 3Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 2Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 3Health News:CSHL scientists discover how a tumor suppressor induces senescence and staves off cancer 2Health News:ActiveStrategy iRound™ is Launched to Enable Seamless Capture of Field-Level Performance Management Data 2Health News:ActiveStrategy iRound™ is Launched to Enable Seamless Capture of Field-Level Performance Management Data 3Health News:Corneal Transplant Not Hurt by Long Preservation Time 2
(Date:8/27/2014)... 2014 Ambit Biosciences (Nasdaq: AMBI ), a ... unmet needs in oncology, autoimmune and inflammatory disease, today announced ... to be held at The New York Palace Hotel in ... 2014. Alan Fuhrman , Ambit,s CFO, will ... candidate, quizartinib, at 1:10 p.m. ET on Wednesday, September 3, ...
(Date:8/27/2014)... Pa. , Aug. 27, 2014   Auxilium Pharmaceuticals ... integrated specialty biopharmaceutical company, today announced that certain members ... Morgan Stanley Healthcare Conference to be held September 8-10, ... Adrian Adams , Chief Executive Officer and President, is ... its product portfolio at 10:55 a.m. ET on Wednesday, ...
(Date:8/26/2014)... , Aug. 27, 2014 Higher ... insurance are fuelling the demand for medical devices ... rise of medical tourism, the inflow of patients ... The market will continue its steady ascent as ... age-related and non-communicable diseases, compelling significant investments in ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 2Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 4
... Antibody (IgM) Test is an ... quantitative detection of antibodies to ... is used as an aid ... thrombosis in individuals with systemic ...
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
Rad-5v signal extraction pulse oximeter™...
... The 8500 Digital Handheld ... universal tool for patients monitoring ... continuous monitoring. As the first ... as a benchmark for durability ...
Medicine Products: